FIAlab Instruments is a leading US manufacturer of flow injection analysis (FIA) and sequential injection analysis (SIA) instrumentation. These instruments are used to automate and streamline many liquid-handling procedures.
They have recently developed a new PAT technology which AstraZeneca and other leading blue-chip companies currently use. This technology reduces costs by $1 million per 100K analyses and eliminates nearly 1 ton of plastic waste. Additionally, its automation capabilities help minimise the risk of contamination and human error.
Trade Horizons is inviting five members of Medilink Midlands to attend a webinar 22 May with the Fialab team. The team will conduct a live demo for your review and will share the advantages of this new technology.
Click here for more information and to register